JPRN-UMIN000007197已完成未知
Assessment of adalimumab self injection in Crohn's disease-Pearl survey - Assessment of adalimumab self injection
Department of Gastroenterology, Fukuoka University Chikushi Hospital0 个研究点目标入组 100 人开始时间: 2012年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who do not give consent to participate in the survey.
研究者
相似试验
招募中
4 期
Control Crohn Safe with episodic adalimumab monotherapy as first line treatment study.Crohn's diseaseNL-OMON52419niversiteit Maastricht158
已完成
不适用
Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic StudyCrohn's DiseaseNCT02450513Universitaire Ziekenhuizen KU Leuven30
已完成
3 期
Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)Crohn's DiseaseNCT00427921Abbott304
招募中
4 期
Control Crohn Safe TrialInflammatory Bowel DiseasesCrohn DiseaseNCT03917303Maastricht University Medical Center158
Unknown
不适用
Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological TherapyCrohn DiseaseNCT04362735Pontifícia Universidade Católica do Paraná100